Known targets — ChEMBL curated mechanism
BTKCACNA1CCACNA1DCACNA1FCACNA1SCACNA2D1CACNA2D2DRD2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQHRH1HTR2AP2RY12
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 18/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.65 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Int131 SCHEMBL634435 | 0.88 | PPARG (0.86) | PPARGCYP3A4 | |
| SCHEMBL21391656 | 0.86 | PPARG (1.00) | PPARGCYP3A4ALPL | |
| Int131 SCHEMBL29404335 | 0.79 | PPARG (1.00) | PPARGCYP3A4 | |
| Int131 SCHEMBL634767 | 0.79 | PPARG (1.00) | PPARGCYP3A4 | |
| Int131 SCHEMBL30035369 | 0.79 | PPARG (1.00) | PPARGCYP3A4 | |
| SCHEMBL22203939 | 0.79 | PPARG (0.83) | PPARGCYP3A4ALPL | |
| Int131 SCHEMBL635008 | 0.78 | PPARG (0.98) | PPARGCYP3A4 | |
| SCHEMBL10060331 | 0.78 | PPARG (0.82) | PPARGCYP3A4ALPL | |
| SCHEMBL22732150 | 0.77 | PPARG (0.79) | PPARGCYP3A4ALPL | |
| SCHEMBL7996313 | 0.77 | PPARG (0.83) | PPARGCYP3A4ALPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009111078-A2 | COMBINATION OF A PPARY AGONIST AND A DIPEPTIDYL PEPTIDASE-INHIBITOR FOR THE TREATMENT OF DIABETES AND OBESITY | INTEKRIN THERAPEUTICS, INC. (US) | 2009-09-11 | — | — | WO | disclosed |